Association of Omega-3 Fatty Acid and Epileptic Seizure in Epileptic Patients: A Systematic Review

Makan Pourmasoumi, Nooshin Vosoughi, Seyedeh-Masoumeh DerakhshandehRishehri, Mostafa Assarroudi, Motahar Heidari-Beni

Abstract


The evidence on the association between omega-3 consumption and epileptic seizure is inconsistent. Therefore, we have conducted this systematic review to clarify the possible relationship. Original articles were searched in electronic databases (PubMed, Scopus, Google Scholar, Cochrane, and Ovid) and by reviewing the reference lists of retrieved articles. The main evaluated outcome was the epileptic seizures. We included the English language studies that reported the original data on the effect of omega-3 on epileptic human patients. We included the nine articles with 230 patients in the present systematic review. The mean ± standard deviation age of them was about 31.01 ± 14.99 years. The average of study duration was 22 ± 15.27 weeks. Omega-3 fatty acid supplements were defined as the sum of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) (1100 mg/d); as the sum of EPA, DHA, and alpha-linolenic acid (5 g/d); and as the sum of EPA alone (565 mg/d) in different studies. Among the nine studies, four studies reported a significant positive association between omega-3 fatty acids and epileptic seizures. However, power and quality of these studies are low, and we cannot consider the beneficial effect of omega-3 on seizures. In addition, five studies did not reveal any significant effect. Majority of the included studies did not show a significant association between omega-3 and epileptic seizure in epileptic patients, but further studies are necessary. It is controversial whether omega-3 fatty acids can produce positive effects on epileptic patients or not.

Keywords: Docosahexaenoic acid, eicosapentaenoic acid, epilepsy, omega-3


Full Text:

PDF

References


Cunnane SC, Musa K, Ryan MA, Whiting S, Fraser DD.

Potential role of polyunsaturates in seizure protection achieved

with the ketogenic diet. Prostaglandins Leukot Essent Fatty

Acids 2002;67:131-5.

Forsgren L. Epidemiology and prognosis of epilepsy and its

treatment. The Treatment of Epilepsy. Malden: Blackwell

Science Oxford; 2004. p. 21-42.

Forsgren L, Beghi E, Oun A, Sillanpää M. The epidemiology

of epilepsy in Europe – A systematic review. Eur J Neurol

;12:245-53.

Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy

and unprovoked seizures in Rochester, Minnesota: 1935-1984.

Epilepsia 1993;34:453-68.

Kotsopoulos IA, van Merode T, Kessels FG, de Krom MC,

Knottnerus JA. Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures. Epilepsia

;43:1402-9.

Preux PM, Druet-Cabanac M. Epidemiology and aetiology of

epilepsy in sub-Saharan Africa. Lancet Neurol 2005;4:21-31.

Scorza CA, Cavalheiro EA, Scorza FA. The prescription of

omega-3 fatty acids for people with epilepsy by Brazilian

epileptologists: We know the goal, but do we know the price?

Epilepsy Behav 2013;27:422-3.

Ngugi AK, Kariuki SM, Bottomley C, Kleinschmidt I,

Sander JW, Newton CR. Incidence of epilepsy: A systematic

review and meta-analysis. Neurology 2011;77:1005-12.

Yuen AW, Sander JW, Fluegel D, Patsalos PN, Bell GS,

Johnson T, et al. Omega-3 fatty acid supplementation in patients

with chronic epilepsy: A randomized trial. Epilepsy Behav

;7:253-8.

Okuyama H, Kobayashi T, Watanabe S. Dietary fatty acids – The

N-6/N-3 balance and chronic elderly diseases. Excess linoleic

acid and relative N-3 deficiency syndrome seen in Japan. Prog

Lipid Res 1996;35:409-57.

Horrocks LA, Yeo YK. Health benefits of docosahexaenoic

acid (DHA) Pharmacol Res 1999;40:211-25.

Connor WE, Neuringer M, Reisbick S. Essential fatty acids: The

importance of n-3 fatty acids in the retina and brain. Nutr Rev

;50:21-9.

Mirnikjoo B, Brown SE, Kim HF, Marangell LB, Sweatt JD,

Weeber EJ. Protein kinase inhibition by omega-3 fatty acids.

J Biol Chem 2001;276:10888-96.

McNamara RK, Carlson SE. Role of omega-3 fatty acids in

brain development and function: Potential implications for the

pathogenesis and prevention of psychopathology. Prostaglandins

Leukot Essent Fatty Acids 2006;75:329-49.

DeGiorgio CM, Scorza FA. Epilepsy and behavior:

th anniversary research on omega-3 fatty acids for epilepsy.

Epilepsy Behav 2014;40:124-5.

Bourre JM, Pascal G, Durand G, Masson M, Dumont O,

Piciotti M. Alterations in the fatty acid composition of rat

brain cells (neurons, astrocytes, and oligodendrocytes) and of

subcellular fractions (myelin and synaptosomes) induced by a

diet devoid of n-3 fatty acids. J Neurochem 1984;43:342-8.

Lauritzen I, Blondeau N, Heurteaux C, Widmann C,

Romey G, Lazdunski M. Polyunsaturated fatty acids are potent

neuroprotectors. EMBO J 2000;19:1784-93.

Bazan NG. Homeostatic regulation of photoreceptor cell

integrity: Significance of the potent mediator neuroprotectin D1

biosynthesized from docosahexaenoic acid: The Proctor Lecture.

Invest Ophthalmol Vis Sci 2007;48:4866-81.

Bazan NG, Molina MF, Gordon WC. Docosahexaenoic

acid signalolipidomics in nutrition: Significance in aging,

neuroinflammation, macular degeneration, Alzheimer’s, and other

neurodegenerative diseases. Annu Rev Nutr 2011;31:321-51.

Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic

diet. Epilepsia 2007;48:43-58.

Leaf A. The electrophysiologic basis for the antiarrhythmic and

anticonvulsant effects of n-3 polyunsaturated fatty acids: Heart

and brain. Lipids 2001;36:S107-10.

Bernardino L, Ferreira R, Cristóvao AJ, Sales F, Malva JO.

Inflammation and neurogenesis in temporal lobe epilepsy. Curr

Drug Targets CNS Neurol Disord 2005;4:349-60.

Seebungkert B, Lynch JW. Effects of polyunsaturated fatty acids

on voltage-gated K+and Na+channels in rat olfactory receptor

neurons. Eur J Neurosci 2002;16:2085-94.

Xiao YF, Ma L, Wang SY, Josephson ME, Wang GK, Morgan JP,

et al. Potent block of inactivation-deficient Na+ channels by

n-3 polyunsaturated fatty acids. Am J Physiol Cell Physiol

;290:C362-70.

Vreugdenhil M, Bruehl C, Voskuyl RA, Kang JX, Leaf A,

Wadman WJ. Polyunsaturated fatty acids modulate sodium and

calcium currents in CA1 neurons. Proc Natl Acad Sci U S A

;93:12559-63.

Xiao Y, Li X. Polyunsaturated fatty acids modify mouse

hippocampal neuronal excitability during excitotoxic or

convulsant stimulation. Brain Res 1999;846:112-21.

DeGiorgio CM, Miller PR, Harper R, Gornbein J, Schrader L,

Soss J, et al. Fish oil (n-3 fatty acids) in drug resistant epilepsy:

A randomised placebo-controlled crossover study. J Neurol

Neurosurg Psychiatry 2015;86:65-70.

Dahlin M, Hjelte L, Nilsson S, Amark P. Plasma phospholipid

fatty acids are influenced by a ketogenic diet enriched with

n-3 fatty acids in children with epilepsy. Epilepsy Res

;73:199-207.

DeGiorgio CM, Miller P, Meymandi S, Gornbein JA. n-3 fatty

acids (fish oil) for epilepsy, cardiac risk factors, and risk of

SUDEP: Clues from a pilot, double-blind, exploratory study.

Epilepsy Behav 2008;13:681-4.

Puri BK, Koepp MJ, Holmes J, Hamilton G, Yuen AW.

A 31-phosphorus neurospectroscopy study of omega-3 long-chain

polyunsaturated fatty acid intervention with eicosapentaenoic

acid and docosahexaenoic acid in patients with chronic

refractory epilepsy. Prostaglandins Leukot Essent Fatty Acids

;77:105-7.

Bromfield E, Dworetzky B, Hurwitz S, Eluri Z, Lane L,

Replansky S, et al. A randomized trial of polyunsaturated

fatty acids for refractory epilepsy. Epilepsy Behav

;12:187-90.

Schlanger S, Shinitzky M, Yam D. Diet enriched with omega-3

fatty acids alleviates convulsion symptoms in epilepsy patients.

Epilepsia 2002;43:103-4.

Yuen AW, Flugel D, Poepel A, Bell GS, Peacock JL, Sander JW.

Non-randomized open trial of eicosapentaenoic acid (EPA), an

omega-3 fatty acid, in ten people with chronic epilepsy. Epilepsy

Behav 2012;23:370-2.

Reda DM, Abd-El-Fatah NK, Omar Tel-S, Darwish OA. Fish oil

intake and seizure control in children with medically resistant

epilepsy. N Am J Med Sci 2015;7:317-21.

Yehuda S, Carasso RL, Mostofsky DI. Essential fatty acid

preparation (SR-3) raises the seizure threshold in rats. Eur J

Pharmacol 1994;254:193-8.

Bazan NG, Musto AE, Knott EJ. Endogenous signaling by

omega-3 docosahexaenoic acid-derived mediators sustains

homeostatic synaptic and circuitry integrity. Mol Neurobiol

;44:216-22.